73 related articles for article (PubMed ID: 22998861)
1. Asleep at the switch: MEK kinases control transit to gliogenesis in developing cortex.
Zhou J; Stiles CD
Neuron; 2012 Sep; 75(6):940-2. PubMed ID: 22998861
[TBL] [Abstract][Full Text] [Related]
2. MEK Is a Key Regulator of Gliogenesis in the Developing Brain.
Li X; Newbern JM; Wu Y; Morgan-Smith M; Zhong J; Charron J; Snider WD
Neuron; 2012 Sep; 75(6):1035-50. PubMed ID: 22998872
[TBL] [Abstract][Full Text] [Related]
3. MEK ablation in MCF-7 cells blocks DNA synthesis induced by serum, but not by estradiol or growth factors.
Estes NR; Thottassery JV; Westbrook L; Kern FG
Int J Oncol; 2006 Dec; 29(6):1573-80. PubMed ID: 17088999
[TBL] [Abstract][Full Text] [Related]
4. Functional redundancy of the kinases MEK1 and MEK2: Rescue of the Mek1 mutant phenotype by Mek2 knock-in reveals a protein threshold effect.
Aoidi R; Maltais A; Charron J
Sci Signal; 2016 Jan; 9(412):ra9. PubMed ID: 26814233
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of MEK1 and MEK2 during mouse development.
Alessandrini A; Brott BK; Erikson RL
Cell Growth Differ; 1997 May; 8(5):505-11. PubMed ID: 9149902
[TBL] [Abstract][Full Text] [Related]
6. ERK1/2 can feedback-regulate cellular MEK1/2 levels.
Hong SK; Wu PK; Karkhanis M; Park JI
Cell Signal; 2015 Oct; 27(10):1939-48. PubMed ID: 26163823
[TBL] [Abstract][Full Text] [Related]
7. MEK2 is a kinase related to MEK1 and is differentially expressed in murine tissues.
Brott BK; Alessandrini A; Largaespada DA; Copeland NG; Jenkins NA; Crews CM; Erikson RL
Cell Growth Differ; 1993 Nov; 4(11):921-9. PubMed ID: 8297798
[TBL] [Abstract][Full Text] [Related]
8. Aberrant extracellular signal-regulated kinase (ERK)1/2 signalling in suicide brain: role of ERK kinase 1 (MEK1).
Dwivedi Y; Rizavi HS; Zhang H; Roberts RC; Conley RR; Pandey GN
Int J Neuropsychopharmacol; 2009 Nov; 12(10):1337-54. PubMed ID: 19835659
[TBL] [Abstract][Full Text] [Related]
9. MEK1 and MEK2 differentially control the duration and amplitude of the ERK cascade response.
Kocieniewski P; Lipniacki T
Phys Biol; 2013 Jun; 10(3):035006. PubMed ID: 23735655
[TBL] [Abstract][Full Text] [Related]
10. Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition.
Ohren JF; Chen H; Pavlovsky A; Whitehead C; Zhang E; Kuffa P; Yan C; McConnell P; Spessard C; Banotai C; Mueller WT; Delaney A; Omer C; Sebolt-Leopold J; Dudley DT; Leung IK; Flamme C; Warmus J; Kaufman M; Barrett S; Tecle H; Hasemann CA
Nat Struct Mol Biol; 2004 Dec; 11(12):1192-7. PubMed ID: 15543157
[TBL] [Abstract][Full Text] [Related]
11. Crucial requirement of ERK/MAPK signaling in respiratory tract development.
Boucherat O; Nadeau V; Bérubé-Simard FA; Charron J; Jeannotte L
Development; 2014 Aug; 141(16):3197-211. PubMed ID: 25100655
[TBL] [Abstract][Full Text] [Related]
12. Truncated tyrosine kinase B brain-derived neurotrophic factor receptor directs cortical neural stem cells to a glial cell fate by a novel signaling mechanism.
Cheng A; Coksaygan T; Tang H; Khatri R; Balice-Gordon RJ; Rao MS; Mattson MP
J Neurochem; 2007 Mar; 100(6):1515-30. PubMed ID: 17286628
[TBL] [Abstract][Full Text] [Related]
13. Germline mutations of MEK in cardio-facio-cutaneous syndrome are sensitive to MEK and RAF inhibition: implications for therapeutic options.
Senawong T; Phuchareon J; Ohara O; McCormick F; Rauen KA; Tetsu O
Hum Mol Genet; 2008 Feb; 17(3):419-30. PubMed ID: 17981815
[TBL] [Abstract][Full Text] [Related]
14. Stimulation of mitogen-activated protein kinase kinases (MEK1/2) by mu-, delta- and kappa-opioid receptor agonists in the rat brain: regulation by chronic morphine and opioid withdrawal.
Asensio VJ; Miralles A; García-Sevilla JA
Eur J Pharmacol; 2006 Jun; 539(1-2):49-56. PubMed ID: 16678156
[TBL] [Abstract][Full Text] [Related]
15. Map2k1 and Map2k2 genes contribute to the normal development of syncytiotrophoblasts during placentation.
Nadeau V; Guillemette S; Bélanger LF; Jacob O; Roy S; Charron J
Development; 2009 Apr; 136(8):1363-74. PubMed ID: 19304888
[TBL] [Abstract][Full Text] [Related]
16. MAP kinase: it's been longer than fifteen minutes.
Sturgill TW
Biochem Biophys Res Commun; 2008 Jun; 371(1):1-4. PubMed ID: 18406346
[TBL] [Abstract][Full Text] [Related]
17. MEK1/2 dual-specificity protein kinases: structure and regulation.
Roskoski R
Biochem Biophys Res Commun; 2012 Jan; 417(1):5-10. PubMed ID: 22177953
[TBL] [Abstract][Full Text] [Related]
18. RNAi-mediated MEK1 knock-down prevents ERK1/2 activation and abolishes human hepatocarcinoma growth in vitro and in vivo.
Gailhouste L; Ezan F; Bessard A; Frémin C; Rageul J; Langouët S; Baffet G
Int J Cancer; 2010 Mar; 126(6):1367-77. PubMed ID: 19816936
[TBL] [Abstract][Full Text] [Related]
19. BDNF/MAPK/ERK-induced BMP7 expression in the developing cerebral cortex induces premature radial glia differentiation and impairs neuronal migration.
Ortega JA; Alcántara S
Cereb Cortex; 2010 Sep; 20(9):2132-44. PubMed ID: 20038543
[TBL] [Abstract][Full Text] [Related]
20. IQGAP1 is a scaffold for mitogen-activated protein kinase signaling.
Roy M; Li Z; Sacks DB
Mol Cell Biol; 2005 Sep; 25(18):7940-52. PubMed ID: 16135787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
